KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Invested Capital: 2011-2022

Historic Return on Invested Capital for Emergent BioSolutions (EBS) over the last 12 years, with Dec 2022 value amounting to -0.06%.

  • Emergent BioSolutions' Return on Invested Capital was N/A to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year change of. This contributed to the annual value of -0.06% for FY2022, which is 17.00% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Return on Invested Capital of -0.06% as of FY2022, which was down 160.59% from 0.10% recorded in FY2021.
  • In the past 5 years, Emergent BioSolutions' Return on Invested Capital ranged from a high of 0.15% in FY2020 and a low of -0.06% during FY2022.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.10% (2021), whereas its average is 0.06%.
  • Per our database at Business Quant, Emergent BioSolutions' Return on Invested Capital increased by 11bps in 2020 and then decreased by 17bps in 2022.
  • Emergent BioSolutions' Return on Invested Capital (Yearly) stood at 0.05% in 2018, then dropped by 1bps to 0.04% in 2019, then increased by 11bps to 0.15% in 2020, then dropped by 5bps to 0.10% in 2021, then decreased by 17bps to -0.06% in 2022.